12:00 AM
 | 
Feb 07, 2011
 |  BioCentury  |  Finance

EPS Watch

EPS Watch

Company 4Q10 EPS est 4Q10 EPS actual Outcome Growth from 4Q09 2/4 cls Wk chg % chg Mcap chg 2/4 Mcap
Affymetrix Inc. (NASDAQ:AFFX) $0.02 $0.06 Beat by $0.04 50% $5.09 $0.22 5% $15.1 $349.1
4Q10 revenue for the microarray maker was down 4% to $84.9M from $88.8M in 4Q09. The Street was expecting $85M. Affymetrix did not provide FY11 guidance.
Allergan Inc. (NYSE:AGN) $0.89 $0.88 Missed by $0.01 13% $71.61 $2.53 4% $769.4 $21,776.6
4Q10 revenue increased 7% to $1.3B from $1.2B in 4Q09. Figures include a negative foreign currency exchange impact. The company gave FY11 non-GAAP EPS and revenue guidance of $3.54-$3.60 and $5-$5.2B, respectively, and 1Q11 guidance of $0.71-$0.73 and $1.17-$1.22B, respectively. The company expects U.S. healthcare reform and European price cuts to results in $100M in incremental costs in FY11.
Biogen Idec Inc. (NASDAQ:BIIB) $1.23 $1.42 Beat by $0.19 ...

Read the full 1087 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >